Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

USA - NASDAQ:CENX - US1564311082 - Common Stock

26.09 USD
+1.57 (+6.4%)
Last: 9/12/2025, 8:00:00 PM
26.25 USD
+0.16 (+0.61%)
After Hours: 9/12/2025, 8:00:00 PM
Fundamental Rating

4

CENX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. There are concerns on the financial health of CENX while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on CENX.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CENX was profitable.
In the past year CENX had a positive cash flow from operations.
In the past 5 years CENX reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CENX reported negative operating cash flow in multiple years.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

The Return On Assets of CENX (5.71%) is better than 77.56% of its industry peers.
With an excellent Return On Equity value of 15.35%, CENX belongs to the best of the industry, outperforming 87.18% of the companies in the same industry.
CENX has a better Return On Invested Capital (9.44%) than 81.41% of its industry peers.
CENX had an Average Return On Invested Capital over the past 3 years of 3.18%. This is significantly below the industry average of 13.00%.
The 3 year average ROIC (3.18%) for CENX is below the current ROIC(9.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.71%
ROE 15.35%
ROIC 9.44%
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Profit Margin of CENX (4.57%) is better than 71.15% of its industry peers.
With a decent Operating Margin value of 7.40%, CENX is doing good in the industry, outperforming 62.18% of the companies in the same industry.
In the last couple of years the Operating Margin of CENX has grown nicely.
CENX has a Gross Margin of 10.07%. This is comparable to the rest of the industry: CENX outperforms 41.67% of its industry peers.
In the last couple of years the Gross Margin of CENX has grown nicely.
Industry RankSector Rank
OM 7.4%
PM (TTM) 4.57%
GM 10.07%
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CENX is destroying value.
The number of shares outstanding for CENX has been increased compared to 1 year ago.
The number of shares outstanding for CENX has been increased compared to 5 years ago.
CENX has a worse debt/assets ratio than last year.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CENX has an Altman-Z score of 1.77. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
CENX has a Altman-Z score of 1.77. This is in the lower half of the industry: CENX underperforms 68.59% of its industry peers.
CENX has a Debt/Equity ratio of 0.64. This is a neutral value indicating CENX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.64, CENX is doing worse than 80.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACC0.95
WACC9.95%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CENX has a Current Ratio of 1.75. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CENX (1.75) is worse than 61.54% of its industry peers.
A Quick Ratio of 0.61 indicates that CENX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, CENX is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.61
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

CENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 641.67%, which is quite impressive.
Looking at the last year, CENX shows a quite strong growth in Revenue. The Revenue has grown by 15.38% in the last year.
The Revenue has been growing slightly by 3.87% on average over the past years.
EPS 1Y (TTM)641.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2900%
Revenue 1Y (TTM)15.38%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%12%

3.2 Future

CENX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.41% yearly.
Based on estimates for the next years, CENX will show a quite strong growth in Revenue. The Revenue will grow by 10.44% on average per year.
EPS Next Y64.13%
EPS Next 2Y59.98%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue Next Year21.11%
Revenue Next 2Y11.33%
Revenue Next 3Y10.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.66, which indicates a correct valuation of CENX.
Based on the Price/Earnings ratio, CENX is valued cheaper than 89.74% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CENX is valued a bit cheaper.
The Price/Forward Earnings ratio is 9.27, which indicates a very decent valuation of CENX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CENX indicates a rather cheap valuation: CENX is cheaper than 85.90% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CENX to the average of the S&P500 Index (22.73), we can say CENX is valued rather cheaply.
Industry RankSector Rank
PE 14.66
Fwd PE 9.27
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CENX is valued a bit cheaper than 73.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CENX may justify a higher PE ratio.
A more expensive valuation may be justified as CENX's earnings are expected to grow with 62.41% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y59.98%
EPS Next 3Y62.41%

More info and screens

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (9/12/2025, 8:00:00 PM)

After market: 26.25 +0.16 (+0.61%)

26.09

+1.57 (+6.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners58.55%
Inst Owner Change3.59%
Ins Owners0.98%
Ins Owner Change0.05%
Market Cap2.44B
Analysts82.5
Price Target27.54 (5.56%)
Short Float %10.47%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.64%
Min EPS beat(2)-36.41%
Max EPS beat(2)-10.87%
EPS beat(4)2
Avg EPS beat(4)21.32%
Min EPS beat(4)-36.41%
Max EPS beat(4)124.6%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.14%
Min Revenue beat(2)0.68%
Max Revenue beat(2)7.6%
Revenue beat(4)3
Avg Revenue beat(4)6.75%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)20.06%
Revenue beat(8)6
Avg Revenue beat(8)5.91%
Revenue beat(12)8
Avg Revenue beat(12)4.73%
Revenue beat(16)9
Avg Revenue beat(16)2.71%
PT rev (1m)20%
PT rev (3m)19.12%
EPS NQ rev (1m)22.06%
EPS NQ rev (3m)31.75%
EPS NY rev (1m)-27.76%
EPS NY rev (3m)-26.71%
Revenue NQ rev (1m)7.95%
Revenue NQ rev (3m)9.25%
Revenue NY rev (1m)5.44%
Revenue NY rev (3m)9.2%
Valuation
Industry RankSector Rank
PE 14.66
Fwd PE 9.27
P/S 1
P/FCF N/A
P/OCF 41.35
P/B 3.36
P/tB 3.36
EV/EBITDA 11
EPS(TTM)1.78
EY6.82%
EPS(NY)2.82
Fwd EY10.79%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.63
OCFY2.42%
SpS26.06
BVpS7.76
TBVpS7.76
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.71%
ROE 15.35%
ROCE 12.01%
ROIC 9.44%
ROICexc 9.7%
ROICexgc 9.7%
OM 7.4%
PM (TTM) 4.57%
GM 10.07%
FCFM N/A
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)3.31%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y6.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.18%
ROICexc growth 5YN/A
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
F-Score6
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 99.02%
Cap/Sales 3.32%
Interest Coverage 4.72
Cash Conversion 22.53%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 0.61
Altman-Z 1.77
F-Score6
WACC9.95%
ROIC/WACC0.95
Cap/Depr(3y)115.12%
Cap/Depr(5y)92.4%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)641.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2900%
EPS Next Y64.13%
EPS Next 2Y59.98%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue 1Y (TTM)15.38%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%12%
Revenue Next Year21.11%
Revenue Next 2Y11.33%
Revenue Next 3Y10.44%
Revenue Next 5YN/A
EBIT growth 1Y1305.47%
EBIT growth 3Y20.15%
EBIT growth 5YN/A
EBIT Next Year187.14%
EBIT Next 3Y66.3%
EBIT Next 5YN/A
FCF growth 1Y81.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y232.06%
OCF growth 3YN/A
OCF growth 5YN/A